This event has now ended. If you'd like to visit, you can view current public events at Garvan or register for one of our upcoming seminars.


The inaugural Community Breast Cancer Research Update is a unique interface between the community and breast cancer researchers. Held as part of the 2017 Australian Translational Breast Cancer Research Symposium on February 14, the 2-hour session aims to make the latest advances in breast cancer research and medicine accessible to the public, giving attendees the rare opportunity to hear and interact with leading local and international breast cancer researchers.

Hosted by the Garvan Research Foundation and sponsored by Estée Lauder Companies, as part of its global Breast Cancer Awareness Campaign, the Update will explore personalised medicine and the translation of breast cancer research from “the bench to the bedside” from an international and local perspective. 

The Community Breast Cancer Research Update program will feature:

  • A keynote address from Prof Lisa Carey, University of North Carolina, called ‘Personalised medicine in breast cancer: insights from key research breakthroughs’
  • Updates from A/Profs Alex Swarbrick and Elgene Lim, about breast cancer discoveries and clinical research at the Garvan Institute 
  • An open Q&A style discussion with leading breast cancer researchers, clinicians, clinicians and representatives from breast cancer organisations (advocacy and research). 

 To learn more about Garvan's breast cancer research please click here.



Where to goNAB Auditorium
Garvan Institute of Medical research
384 Victoria Street
Darlinghurst, NSW 2010

Access to the Auditorium is via Burton Street

Proudly supported by:

Garvan Research Foundation | St Vincents Curran Foundation | Estee Lauder

Your personal information

Personal Information is collected to process donations, event registrations, set up online fundraising pages, send receipts, updates and appeals. You can choose what you receive at any time. Read Garvan’s collection statement to see how we use your information.